These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 2899556

  • 1. Arteriosclerosis risk in women and the role of oral contraceptive progestins.
    Knopp RH.
    Int J Fertil; 1986; 31 SU [UPDATE]():20-30. PubMed ID: 2899556
    [Abstract] [Full Text] [Related]

  • 2. Arteriosclerosis risk. The roles of oral contraceptives and postmenopausal estrogens.
    Knopp RH.
    J Reprod Med; 1986 Sep; 31(9 Suppl):913-21. PubMed ID: 3772911
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The metabolic impact of oral contraceptives.
    Krauss RM, Burkman RT.
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
    [Abstract] [Full Text] [Related]

  • 6. Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy.
    Burkman RT.
    Fertil Steril; 1988 May; 49(5 Suppl 2):39S-50S. PubMed ID: 3282934
    [Abstract] [Full Text] [Related]

  • 7. Oral contraceptives and cardiovascular risk. Taking a safe course of action.
    Derman RJ.
    Postgrad Med; 1990 Sep 15; 88(4):119-22. PubMed ID: 2204902
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Atherosclerotic risk factors in cardiovascular disease.
    LaRosa JC.
    J Reprod Med; 1986 Sep 15; 31(9 Suppl):906-12. PubMed ID: 3772910
    [Abstract] [Full Text] [Related]

  • 13. [Metabolic impact of current estrogen-progestins and cardiovascular consequences].
    Gaspard U, Lambotte R.
    Bull Mem Acad R Med Belg; 1991 Sep 15; 146(8-10):334-42; discussion 342-5. PubMed ID: 1815814
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Women and ischemic cardiopathy].
    Assmann G, Davignon J, Fernández Cruz A, Gotto AM, Jacotot B, Lewis B, Paoletti R.
    Rev Clin Esp; 1989 Oct 15; 185(6):308-15. PubMed ID: 2695994
    [Abstract] [Full Text] [Related]

  • 17. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
    Speroff L.
    Johns Hopkins Med J; 1982 May 15; 150(5):170-6. PubMed ID: 7043035
    [Abstract] [Full Text] [Related]

  • 18. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V.
    N Engl J Med; 1990 Nov 15; 323(20):1375-81. PubMed ID: 2146499
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.